Prudential PLC Sells 22,063 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Prudential PLC reduced its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 34.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 42,341 shares of the medical device company’s stock after selling 22,063 shares during the period. Prudential PLC’s holdings in Cooper Companies were worth $3,892,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Byrne Asset Management LLC acquired a new position in Cooper Companies during the fourth quarter worth $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter worth about $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $38,000. West Financial Advisors LLC bought a new position in Cooper Companies during the 4th quarter valued at about $49,000. Finally, Atala Financial Inc acquired a new position in Cooper Companies in the fourth quarter valued at about $51,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of COO stock opened at $73.77 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12 month low of $73.34 and a 12 month high of $112.38. The firm has a market cap of $14.75 billion, a price-to-earnings ratio of 37.83, a PEG ratio of 2.25 and a beta of 1.01. The stock has a 50-day moving average price of $87.76 and a 200 day moving average price of $96.24.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Robert W. Baird dropped their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a report on Friday, March 7th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.